Correlation Between Novo Nordisk and ALK Abell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and ALK Abell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and ALK Abell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and ALK Abell AS, you can compare the effects of market volatilities on Novo Nordisk and ALK Abell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of ALK Abell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and ALK Abell.

Diversification Opportunities for Novo Nordisk and ALK Abell

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Novo and ALK is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and ALK Abell AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALK Abell AS and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with ALK Abell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALK Abell AS has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and ALK Abell go up and down completely randomly.

Pair Corralation between Novo Nordisk and ALK Abell

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the ALK Abell. In addition to that, Novo Nordisk is 1.37 times more volatile than ALK Abell AS. It trades about -0.13 of its total potential returns per unit of risk. ALK Abell AS is currently generating about -0.07 per unit of volatility. If you would invest  15,910  in ALK Abell AS on December 30, 2024 and sell it today you would lose (1,560) from holding ALK Abell AS or give up 9.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  ALK Abell AS

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
ALK Abell AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ALK Abell AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Novo Nordisk and ALK Abell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and ALK Abell

The main advantage of trading using opposite Novo Nordisk and ALK Abell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, ALK Abell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALK Abell will offset losses from the drop in ALK Abell's long position.
The idea behind Novo Nordisk AS and ALK Abell AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.